Cargando…
Predicting therapeutic response to oral ketamine for chronic suicidal ideation: a Bayesian network for clinical decision support
BACKGROUND: The glutamatergic modulator ketamine has been shown to result in rapid reductions in both suicidal ideation (SI) and depressive symptoms in clinical trials. There is a practical need for identification of pre-treatment predictors of ketamine response. Previous studies indicate links betw...
Autores principales: | Beaudequin, Denise, Can, Adem T., Dutton, Megan, Jones, Monique, Gallay, Cyrana, Schwenn, Paul, Yang, Cian, Forsyth, Grace, Simcock, Gabrielle, Hermens, Daniel F., Lagopoulos, Jim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594449/ https://www.ncbi.nlm.nih.gov/pubmed/33115424 http://dx.doi.org/10.1186/s12888-020-02925-1 |
Ejemplares similares
-
Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study
por: Can, Adem T., et al.
Publicado: (2021) -
Oral ketamine may offer a solution to the ketamine conundrum
por: Dutton, Megan, et al.
Publicado: (2023) -
A novel, complex systems approach to modelling risk of psychological distress in young adolescents
por: Beaudequin, Denise, et al.
Publicado: (2021) -
Spectral Changes of EEG Following a 6-Week Low-Dose Oral Ketamine Treatment in Adults With Major Depressive Disorder and Chronic Suicidality
por: Anijärv, T E, et al.
Publicado: (2023) -
A unique case of very low‐dose subcutaneous ketamine use: Maintenance option of ketamine for treatment‐resistant depression
por: Can, Adem T., et al.
Publicado: (2022)